Chronic Hand Eczema: In Plain Sight: An Online Activity

Chronic Hand Eczema: In Plain Sight 

This 20-minute Seminar in Depth from the 2025 Winter Clinical Miami and Hawaii conferences features a discussion of the mixed etiology of chronic hand eczema, clinical data for emerging therapies, and management strategies for clinical practice. 

“Patients would prefer a non-steroidal option, a lot of us would prefer a topical if it’s possible, because of safety issues. What we’re seeing with both of these drugs (delgocitinib and ruxolitinib) – very well tolerated, and in terms of the topical ruxolitinib, we didn’t see any of the systemic manifestations or boxed warnings that we’ve seen with the oral JAK inhibitors.” - Dr. Linda Stein Gold

This activity is supported by an educational grant from LEO Pharma.